Table 3.99.
Key considerations for dental management in liver cirrhosis (see text and Liver failure section)
Management modifications* | Comments/possible complications | |
---|---|---|
Risk assessment | 2 | Underlying disease; impaired haemostasis; bacterial peritonitis |
Appropriate dental care | 2 | Antibiotic prophylaxis; avoid hepatotoxic drugs |
Pain and anxiety control | ||
– Local anaesthesia | 1 | Avoid lidocaine |
– Conscious sedation | 2 | Avoid intravenous benzodiazepine |
– General anaesthesia | 3/4 | Avoid halothane |
Patient access and positioning | ||
– Access to dental office | 0 | |
– Timing of treatment | 0 | |
– Patient positioning | 0 | |
Treatment modification | ||
– Oral surgery | 3 | Bleeding tendency; underlying disease; poor wound healing; liability to peritonitis |
– Implantology | 3/5 | Avoid in alcoholism |
– Conservative/Endodontics | 2 | |
– Fixed prosthetics | 2 | |
– Removable prosthetics | 1 | |
– Non-surgical periodontology | 3/5 | See oral surgery |
– Surgical periodontology | 3/5 | See oral surgery |
Hazardous and contraindicated drugs | 2 | Avoid aspirin, NSAIDs, erythromycin estolate, tetracyclines and ketoconazole |
0 = No special considerations. 1 = Caution advised. 2 = Specialised medical advice recommended in some cases. 3 = Specialised medical advice mandatory. 4 = Only to be performed in hospital environment. 5 = Should be avoided.